Pangali Forward P/E: bluebird bio, Inc (BLUE)

Simbol resmi perusahaan bluebirdbio.com (BLUE)

A liquidity crisis and the costly launch of platforms are forcing bluebird bio, Inc. (BLUE) to pivot its sales model. Currently, bluebird bio, Inc. (BLUE) is focusing on the expansion of Lyfgenia to capture the DNA pharma market. The company's projected P/E multiple reflects demand dynamics, where 0.00 represents the most recent metric value. This confirms its status as a gene therapy pioneer developing methods for the complete cure of hereditary blood pathologies.

BLUE - Kapitalisasi marang proyeksi bathi bluebird bio ing rentang 04.07.2022 - 07.06.2025

bluebird bio (BLUE) - rincian metrik lan laporan keuangan

Pambiji fundamental:Bluebird Bio
Produk merek bluebirdbio.com

The assessment of operational business resilience is based on the ratio of market capitalization to expected net income, allowing investors to determine the premium paid for future growth. For bluebird bio, Inc. (BLUE), this logic reflects market confidence in the monetization of an expanded gene therapy portfolio and the expansion of clinics, which is clearly visualized by the company's forward P/E metric.

Perusahaan pesaing

Prakiraan rega marang bathi TEM (Tempus AI, Inc)|Qiagen Group (QGEN) - Pangali forward rega marang bathi|Rega marang bathi mangsa ngarep ionispharma.com IONS|Kapitalisasi marang proyeksi bathi Repligen Corporation (RGEN)|RNA: Prakiraan rega marang bathi|Pangali mangsa ngarep rega marang bathi CRSP (CRISPR Therapeutics Corp)|WGS: Pangali Forward P/E|Rasio prakiraan rega marang bathi Ultragenyx Corp (RARE)|BEAM (Beam Therapeutics Inc) - Pangali Forward P/E|SRPT: Pangali mangsa ngarep rega marang bathi|Rega marang bathi mangsa ngarep Twist Bioscience Corp (TWST)|Prakiraan rega marang bathi 10x Genomics Inc TXG|Intellia Therapeutics, Inc. - Prakiraan rega marang bathi|Pangali mangsa ngarep rega marang bathi STOK|BLFS - Rega marang bathi mangsa ngarep|Wave Life Sciences (WVE) - Prakiraan rega marang bathi|MAZE: Pangali Forward P/E|Sionna Therapeutics, Inc. (SION) - Pangali Forward P/E|Rega marang bathi mangsa ngarep Prime Medicine, Inc.|TSHA (Taysha) - Rasio kapitalisasi marang bathi mangsa ngarep|Prakiraan rega marang bathi QURE (uniQure Pharma)|Kapitalisasi marang proyeksi bathi meiragtx.com|Rega marang bathi mangsa ngarep REGENXBIO RGNX|SLDB - Prakiraan rega marang bathi|Ocugen, Inc. - Pangali Forward P/E|PACB (Pacific Biosciences of California) - Rasio rega marang bathi mangsa ngarep|BNTC: Pangali Forward P/E|DSGN - Kapitalisasi marang proyeksi bathi|RCKT (Rocket Pharma) - Pangali Forward P/E|Rega marang bathi mangsa ngarep FDMT|Rega marang bathi mangsa ngarep Lexeo Therapeutics, Inc. (LXEO)|Korro Bio Inc. - Rasio rega marang bathi mangsa ngarep|editasmedicine.com - Prakiraan rega marang bathi|Kapitalisasi marang proyeksi bathi silence-therapeutics.com (SLN)|PRQR: Prakiraan rega marang bathi|Rasio prakiraan rega marang bathi codexis.com|SGMO: Pangali Forward P/E|Rasio prakiraan rega marang bathi Nautilus Biotechnology Inc (NAUT)|Prakiraan rega marang bathi MGX|DTIL (Precision BioSciences) - Rasio kapitalisasi marang bathi mangsa ngarep|Rega marang bathi mangsa ngarep Generation Bio Corp (GBIO)|Boundless Bio - Rasio rega marang bathi mangsa ngarep|Rega marang bathi mangsa ngarep Exicure, Inc. XCUR|Pangali mangsa ngarep rega marang bathi IMNN|PHIO - Rega marang bathi mangsa ngarep|Kapitalisasi marang proyeksi bathi Mustang Bio Inc MBIO|RNAZ: Pangali Forward P/E|Rasio rega marang bathi mangsa ngarep BNGO|APDN (Applied DNA Sciences Inc) - Pangali Forward P/E|Rasio rega marang bathi mangsa ngarep IPA (ImmunoPrecise Antibodies)|Pangali Forward P/E OMGA|Prakiraan rega marang bathi Singular Genomics Systems OMIC|Pangali Forward P/E RGLS (regulusrx.com)|Syros Pharmaceuticals Inc. (SYRS) - Rasio prakiraan rega marang bathi|TBIO: Prakiraan rega marang bathi|Pangali mangsa ngarep rega marang bathi TCON (TRACON)|UBX: Pangali Forward P/E